A Validated Investment
in the Future of Neurological Diagnostics
Neurological diseases are the world's leading cause of disability and second leading
cause of death,
with their impact growing rapidly.
DeePic is positioned to support solving this crisis with an intelligent,
validated
platform built to empower clinicians, accelerate diagnostics, and save lives.
A Multi-Billion Dollar Market
Ready for Disruption
Currently, the demand for effective solutions has never been more urgent, and DeePic
is strategically
positioned to capture a significant portion of this high-value market
100 Million+ People
The number of people living with major neurological diseases like MS, stroke, brain tumors, Alzheimer's, and other dementias (WHO)
$135 M (Annual )
$135 million annual addressable market that includes 1B patients, 340K radiologists, and 20K pharmaceutical boxes.
340,000+
The initial target market of specialist radiologists, pharmaceutical firms, and neurology centers across our target regions.
Why We Win
An Integrated Platform in a Fragmented Market
The current market consists of single-function tools. DeePic provides a comprehensive and scalable
ecosystem that enhances efficiency and clinical insight far beyond what fragmented solutions can
offer.
| Feature | icometrix (icobrain) |
Cortechs.ai (NeuroQuant) |
Standalone Tools (e.g., LST) |
DeePic |
|---|---|---|---|---|
| Centralized and Secure Medical Record Sharing |  |
|
 |
|
| Smart Lesion Mapping & Quantification | |
|
|
|
| Lesion Monitoring | |
|
|
|
| Image Quality Enhancement | |
|
|
 |
| AI-Driven Radiology Report Generation | |
|
|
|
| Integrated, All-in-One Clinical Suite | |
|
|
|
1. Unified Platform Advantage
While competitors offer analytics reports, DeePic provides a comprehensive SaaS platform to manage patients, track history, and access a full suite of tools in one place, creating a stickier ecosystem.
2. Unmatched AI Roadmap
Our funding will unlock high-value capabilities in lesion detection and AI super resolution features that current market leaders do not offer, allowing us to leapfrog the competition.
3. Designed for Scalability
Our architecture is built to rapidly incorporate new AI modules for other diseases (e.g., Alzheimer's), allowing us to expand our market reach with superior capital efficiency.
DeePic AI Model for MS Detection
Our AI-powered platform ensures highly precise lesion localization for the primary disease we target multiple sclerosis (MS) surpassing competitors thanks to an innovative AI model trained on a large and diverse dataset, including images from different geographical regions and multiple imaging modalities.
Traction & A Clear Path to Revenue
With our prototype validated and initial market interest
confirmed through networking
with many radiologists
and pharmaceutical companies, we have established a
clear and
actionable plan for market entry and revenue
generation.
Annual income
Paying clients
Annual Customers growth
Connect with Us
Join us in accelerating our commercial launch, securing regulatory clearances,
and shaping the future of neurological diagnostics.